119 related articles for article (PubMed ID: 8411824)
1. [The local relapse of prostatic cancer and initial local treatment].
Maezawa H; Komatsu H; Furuya T; Tago K; Ueno A
Nihon Hinyokika Gakkai Zasshi; 1993 Sep; 84(9):1685-9. PubMed ID: 8411824
[TBL] [Abstract][Full Text] [Related]
2. High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer.
Cher ML; Shinohara K; Breslin S; Vapnek J; Carroll PR
Br J Urol; 1995 Jun; 75(6):771-7. PubMed ID: 7542137
[TBL] [Abstract][Full Text] [Related]
3. Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression.
Zincke H; Utz DC; Taylor WF
J Urol; 1986 Jun; 135(6):1199-205. PubMed ID: 3086572
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for the development of distant metastases in patients undergoing pelvic lymphadenectomy for prostatic cancer.
Schmidt JD; McLaughlin AP; Saltzstein SL; Garcia-Reyes R
Am J Surg; 1982 Jul; 144(1):131-5. PubMed ID: 7091521
[TBL] [Abstract][Full Text] [Related]
5. Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome.
Zincke H
Urology; 1989 May; 33(5 Suppl):27-36. PubMed ID: 2775377
[TBL] [Abstract][Full Text] [Related]
6. Early endocrine therapy versus radical prostatectomy combined with early endocrine therapy for stage D1 prostate cancer.
Schmeller N; Lubos W
Br J Urol; 1997 Feb; 79(2):226-34. PubMed ID: 9052475
[TBL] [Abstract][Full Text] [Related]
7. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.
Messing EM; Manola J; Sarosdy M; Wilding G; Crawford ED; Trump D
N Engl J Med; 1999 Dec; 341(24):1781-8. PubMed ID: 10588962
[TBL] [Abstract][Full Text] [Related]
8. Treatment options for patients with stage D1 (T0-3,N1-2,M0) adenocarcinoma of prostate.
Zincke H; Utz DC; Thulé PM; Taylor WF
Urology; 1987 Oct; 30(4):307-15. PubMed ID: 3660520
[TBL] [Abstract][Full Text] [Related]
9. [Extended salvage pelvic and retroperitoneal lymph node dissection due to prostate cancer relapse].
Osmonov DK; Aksenov AV; Jünemann KP
Aktuelle Urol; 2013 Jan; 44(1):50-2. PubMed ID: 23325670
[TBL] [Abstract][Full Text] [Related]
10. [Early results following radical prostatectomy in patients with capsule invasion, seminal vesicle infiltration and micrometastases].
Terhorst B; Friedrichs R
Urologe A; 1990 Mar; 29(2):91-5. PubMed ID: 2330669
[TBL] [Abstract][Full Text] [Related]
11. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for stage C or D1 adenocarcinoma of the prostate: possible beneficial effect of adjuvant treatment.
Zincke H
NCI Monogr; 1988; (7):109-15. PubMed ID: 3173496
[TBL] [Abstract][Full Text] [Related]
12. Stage D1 prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy.
Cheng CW; Bergstralh EJ; Zincke H
Cancer; 1993 Feb; 71(3 Suppl):996-1004. PubMed ID: 7679047
[TBL] [Abstract][Full Text] [Related]
13. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
14. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for Stage C adenocarcinoma of prostate.
Zincke H; Utz DC; Benson RC; Patterson DE
Urology; 1984 Dec; 24(6):532-9. PubMed ID: 6506391
[TBL] [Abstract][Full Text] [Related]
15. [A clinical and pathological study of radical prostatectomy for prostate cancer].
Taguchi I; Okaneya T; Yoneyama T; Hosaka K; Komatsu H; Misawa K; Tsuruta T; Komiyama I; Kiyokawa H; Murata Y; Kawakami M
Nihon Hinyokika Gakkai Zasshi; 1996 Apr; 87(4):772-9. PubMed ID: 8691700
[TBL] [Abstract][Full Text] [Related]
16. Impact of Radical Prostatectomy on Long-Term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration.
Bhindi B; Rangel LJ; Mason RJ; Gettman MT; Frank I; Kwon ED; Tollefson MK; Thompson RH; Boorjian SA; Karnes RJ
J Urol; 2017 Jul; 198(1):86-91. PubMed ID: 28130104
[TBL] [Abstract][Full Text] [Related]
17. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison.
Ghavamian R; Bergstralh EJ; Blute ML; Slezak J; Zincke H
J Urol; 1999 Apr; 161(4):1223-7; discussion 1227-8. PubMed ID: 10081874
[TBL] [Abstract][Full Text] [Related]
18. Association of plasma intermedin levels with progression and metastasis in men after radical prostatectomy for localized prostatic cancer.
Wang XL; Wang YY; He HD; Xie X; Yu ZJ; Pan YM
Cancer Biomark; 2015; 15(6):799-805. PubMed ID: 26406405
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiation therapy in patients upstaged to stage C or D1 disease after radical prostatectomy.
Sidi AA; Lange PH
Eur Urol; 1987; 13(4):238-41. PubMed ID: 3653164
[TBL] [Abstract][Full Text] [Related]
20. Familial prostate cancer: a different disease?
Kupelian PA; Klein EA; Witte JS; Kupelian VA; Suh JH
J Urol; 1997 Dec; 158(6):2197-201. PubMed ID: 9366343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
